Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 218
8
Diseases
6
Unique genes
0.390
Avg. similarity score
Brachyrachia
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Brachyrachia
Congenital benign spinal muscular atrophy
Digital arthropathy-brachydactyly, familial
Parastremmatic dwarfism
Scapuloperoneal spinal muscular atrophy
Brachyolmia
TRPV4-related bone disorder
Urination disorders
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Brachyrachia | 7 | 7 | 1 |
| Congenital benign spinal muscular atrophy | 7 | 7 | 1 |
| Digital arthropathy-brachydactyly, familial | 7 | 7 | 1 |
| Parastremmatic dwarfism | 7 | 7 | 1 |
| Scapuloperoneal spinal muscular atrophy | 7 | 7 | 1 |
| Brachyolmia | 5 | 5 | 3 |
| TRPV4-related bone disorder | 5 | 5 | 1 |
| Urination disorders | 5 | 5 | 4 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TRPV4 | 8 / 8 | Brachyolmia, Brachyrachia, Congenital benign spinal muscular atrophy, Digital arthropathy-brachydactyly, familial and 4 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Vitamin E | Reactome | 1 / 1 | 2,002× | 5.00e-4 | 7.96e-3 ✓ sig. |
| Defective PAPSS2 causes SEMD-PA | Reactome | 1 / 1 | 2,002× | 5.00e-4 | 7.96e-3 ✓ sig. |
| Sulfur cycle | KEGG | 1 / 2 | 1,001× | 9.99e-4 | 1.35e-2 ✓ sig. |
| Nitric oxide stimulates guanylate cyclase | Reactome | 1 / 3 | 667× | 1.50e-3 | 1.85e-2 ✓ sig. |
| Transport and synthesis of PAPS | Reactome | 1 / 6 | 334× | 2.99e-3 | 3.07e-2 ✓ sig. |
| Hormone signaling | KEGG | 2 / 219 | 18.3× | 4.73e-3 | 4.23e-2 ✓ sig. |
| Sulfur metabolism | KEGG | 1 / 10 | 200× | 4.99e-3 | 4.37e-2 ✓ sig. |
| Physiological factors | Reactome | 1 / 12 | 167× | 5.98e-3 | 4.92e-2 ✓ sig. |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | Reactome | 1 / 14 | 143× | 6.98e-3 | 5.45e-2 |
| Selenocompound metabolism | KEGG | 1 / 17 | 118× | 8.46e-3 | 6.20e-2 |
| Arginine biosynthesis | KEGG | 1 / 23 | 87.0× | 1.14e-2 | 7.44e-2 |
| TRP channels | Reactome | 1 / 28 | 71.5× | 1.39e-2 | 8.31e-2 |
| ROS and RNS production in phagocytes | Reactome | 1 / 34 | 58.9× | 1.69e-2 | 9.37e-2 |
| African trypanosomiasis | KEGG | 1 / 37 | 54.1× | 1.83e-2 | 9.81e-2 |
| Molecules associated with elastic fibres | Reactome | 1 / 38 | 52.7× | 1.88e-2 | 9.94e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | GO:1902514 | 2 / 12 | 519× | 5.66e-6 | 3.31e-4 ✓ sig. |
| response to hypoxia | GO:0001666 | 3 / 176 | 53.1× | 1.61e-5 | 7.59e-4 ✓ sig. |
| negative regulation of blood pressure | GO:0045776 | 2 / 28 | 222× | 3.24e-5 | 1.29e-3 ✓ sig. |
| vasodilation | GO:0042311 | 2 / 50 | 125× | 1.05e-4 | 3.12e-3 ✓ sig. |
| response to insulin | GO:0032868 | 2 / 83 | 75.0× | 2.89e-4 | 6.54e-3 ✓ sig. |
| hyperosmotic salinity response | GO:0042538 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| blood vessel endothelial cell delamination | GO:0097497 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| synaptic signaling by nitric oxide | GO:0099163 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| positive regulation of sodium ion transmembrane transport | GO:1902307 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| negative regulation of collecting lymphatic vessel constriction | GO:1903815 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| negative regulation of establishment of blood-brain barrier | GO:0090212 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| positive regulation of striated muscle contraction | GO:0045989 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| regulation of response to osmotic stress | GO:0047484 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| response to 3-methylcholanthrene | GO:1904681 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| sulfate assimilation | GO:0000103 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |